Stanley C. Erck

2018

In 2018, Stanley C. Erck earned a total compensation of $4.2M as President and CEO at Novavax, a 50% increase compared to previous year.

Compensation breakdown

Option Awards$3,509,358
Salary$638,040
Other$11,000
Total$4,158,398

Erck received $3.5M in option awards, accounting for 84% of the total pay in 2018.

Erck also received $638K in salary and $11K in other compensation.

Rankings

In 2018, Stanley C. Erck's compensation ranked 2,643rd out of 14,244 executives tracked by ExecPay. In other words, Erck earned more than 81.4% of executives.

ClassificationRankingPercentile
All
2,643
out of 14,244
81st
Division
Manufacturing
981
out of 5,762
83rd
Major group
Chemicals And Allied Products
335
out of 2,125
84th
Industry group
Drugs
273
out of 1,814
85th
Industry
Biological Products, Except Diagnostic Substances
56
out of 339
84th

Pay ratio

Stanley C. Erck's Pay$4,158,398
Median Employee's Pay$123,614
Pay Ratio

34

to 1

In 2018, the annual total compensation of Stanley C. Erck was $4,158,398.

The annual total compensation of the median employee at Novavax was $123,614.

The ratio of Stanley C. Erck's pay to the pay of median employee was therefore 34 to one.

Source: SEC filing on May 16, 2019.

Erck's colleagues

We found three more compensation records of executives who worked with Stanley C. Erck at Novavax in 2018.

2018

Gregory Glenn

Novavax

President, Research and Development

2018

John Trizzino

Novavax

Chief Financial Officer

2018

John Herrmann

Novavax

General Counsel

News

In-depth

You may also like